Cargando…

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

OBJECTIVE: To quantify the background incidence rates of 15 prespecified adverse events of special interest (AESIs) associated with covid-19 vaccines. DESIGN: Multinational network cohort study. SETTING: Electronic health records and health claims data from eight countries: Australia, France, German...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xintong, Ostropolets, Anna, Makadia, Rupa, Shoaibi, Azza, Rao, Gowtham, Sena, Anthony G, Martinez-Hernandez, Eugenia, Delmestri, Antonella, Verhamme, Katia, Rijnbeek, Peter R, Duarte-Salles, Talita, Suchard, Marc A, Ryan, Patrick B, Hripcsak, George, Prieto-Alhambra, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193077/ https://www.ncbi.nlm.nih.gov/pubmed/35727911 http://dx.doi.org/10.1136/bmj.n1435

Ejemplares similares

Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study
por: Li, Xintong, et al.
Publicado: (2021)

Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases
por: Ostropolets, Anna, et al.
Publicado: (2022)

Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network
por: Makadia, Rupa, et al.
Publicado: (2023)

Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
por: Shoaibi, Azza, et al.
Publicado: (2022)

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
por: Voss, Erica A., et al.
Publicado: (2023)

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
por: Burn, Edward, et al.
Publicado: (2022)

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom
por: Burn, Edward, et al.
Publicado: (2022)

Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US
por: Li, Xintong, et al.
Publicado: (2022)

Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study
por: Markus, Aniek F., et al.
Publicado: (2023)

“The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis”
por: Kostka, Kristin, et al.
Publicado: (2023)

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain
por: Burn, Edward, et al.
Publicado: (2022)

Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
por: Moreno-Martos, David, et al.
Publicado: (2023)

Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis
por: Li, Xintong, et al.
Publicado: (2021)

Ranitidine Use and Incident Cancer in a Multinational Cohort
por: You, Seng Chan, et al.
Publicado: (2023)

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
por: Khera, Rohan, et al.
Publicado: (2022)

Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study
por: Reyes, Carlen, et al.
Publicado: (2021)

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study
por: Morales, Daniel R., et al.
Publicado: (2020)

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study
por: Nishimura, Akihiko, et al.
Publicado: (2021)

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
por: Nishimura, Akihiko, et al.
Publicado: (2022)

Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
por: Li, Xintong, et al.
Publicado: (2022)

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
por: Prats-Uribe, Albert, et al.
Publicado: (2021)

Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases
por: Arinze, Johnmary T., et al.
Publicado: (2023)

Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis
por: Tan, Eng Hooi, et al.
Publicado: (2020)

COVID-19 vaccination effectiveness rates by week and sources of bias
por: Ostropolets, Anna, et al.
Publicado: (2021)

COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study
por: Ostropolets, Anna, et al.
Publicado: (2022)

Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study
por: Engelkes, Marjolein, et al.
Publicado: (2020)

Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study
por: Reps, Jenna M, et al.
Publicado: (2021)

Heterologous vaccine regimens against COVID-19
por: Duarte-Salles, Talita, et al.
Publicado: (2021)

Notes on Eight Interesting Obstetrical Cases
por: Jardine, Robert
Publicado: (1905)

Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
por: You, Seng Chan, et al.
Publicado: (2019)

Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance
por: Arshad, Faaizah, et al.
Publicado: (2023)

Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
por: Elhussein, Leena, et al.
Publicado: (2023)

Characterizing physicians’ information needs related to a gap in knowledge unmet by current evidence
por: Ostropolets, Anna, et al.
Publicado: (2020)

Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study
por: Ostropolets, Anna, et al.
Publicado: (2022)

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
por: Khera, Rohan, et al.
Publicado: (2023)

Transforming the Premier Perspective® Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model
por: Makadia, Rupa, et al.
Publicado: (2014)

A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data
por: Khalid, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4agbv72k78p1h7b7pr6tjphkt